Goodwin advises Sapio Santé France on acquisition of EXPERF

Goodwin advised Sapio Santé France SAS, the French subsidiary of the Sapio group, in the acquisition of New Medical Concept, the parent company of the EXPERF group, from the French Bastide group. The transaction concerned the takeover of New Medical Concept, which controls EXPERF, a provider of home healthcare services specialising in infusion and clinical nutrition at home. EXPERF operates an extensive network of 28 agencies and reports annual revenues in excess of €42 million. Its activities include home infusion and clinical nutrition services, notably treatments related to immunotherapy, Parkinson’s disease and diabetes. The acquisition positions Sapio in France as one of the principal players in home infusion care and reinforces its leadership in home artificial nutrition. The operation forms part of Sapio group’s strategic plan to pursue sustainable growth across Europe and to consolidate its standing in the healthcare sector. Goodwin represented Sapio Santé France SAS with a team composed by: Thomas Maitrejean (partner), Rodolphe Amaudric du Chaffaut (associate), Ronan Pflieger (associate) and Marjorie Ladsous (associate) on corporate matters. Goodwin represented Sapio Santé France SAS with a team composed by: Marie Fillon (partner) and Albana Taipi (associate) on intellectual property matters.

Menu

Goodwin advises Sapio Santé France on acquisition of EXPERF

Read the full story

Menu

Goodwin advises Sapio Santé France on acquisition of EXPERF

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads